Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Photodynamic therapy (PDT), a noninvasive therapeutic strategy for cancer treatment, which always suffers from the low reactive oxygen species (ROS) yield of traditional organic dyes. Herein, we present lipid-encapsulated aggregation-induced emission nanoparticles (AIE NPs) that have a high quantum yield (23%) and a maximum two-photon absorption (TPA) cross-section of 560 GM irradiated by near-infrared light (800 nm). The AIE NPs can serve as imaging agents for spatiotemporal imaging of tumor tissues with a penetration depth up to 505 μm on mice melanoma model. Importantly, the AIE NPs can simultaneously generate singlet oxygen (O) and highly toxic hydroxyl radicals (•OH) upon irradiation with 800 nm irradiation for photodynamic tumor ablation. In addition, the AIE NPs can be effectively cleared from the mouse body after the imaging and therapy. This study provides a strategy to develop theranostic agents for cancer image-guided PDT with high brightness, superior photostability, and high biosafety.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1021/acsnano.0c05610 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Strategic Design of Aptamer-Guided Aggregation-Induced Emission Nanoparticles for Targeted Photodynamic Therapy in Breast Cancer.
Adv Sci (Weinh)
September 2025
Department of Chemical and Biological Engineering, Department of Chemistry, Hong Kong Branch of Chinese National Engineering Research Center for Tissue Restoration and Reconstruction, State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science & Technology, Hong Kong, 999077,
Breast cancer (BC), characterized by its heterogeneity and diverse subtypes, necessitates personalized treatment strategies. This study presents MF3Ec-TBPP nanoparticles (NPs) as a promising approach, integrating an aggregation-induced emission (AIE)-based photosensitizer, TBPP, with the MF3Ec aptamer to enhance targeted photodynamic therapy (PDT) for Luminal A subtype BC cells. The nanoparticles also feature a 1, 2-distearoyl-sn-glycero-3-phosphoethanolamine-poly(ethylene glycol) shell and dipalmitoyl phosphatidylcholine (DPPC), which stabilize the structure and inhibit singlet oxygen generation, effectively reducing off-target effects and protecting healthy tissues.
View Article and Find Full Text PDFIntegration of an AIE photosensitizer and a COX-2 inhibitor for synergistic and enhanced tumor therapy.
Bioorg Chem
August 2025
State Key Laboratory of Electroanalytical Chemistry, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, PR China; University of Science and Technology of China, Hefei 230026, PR China. Electronic address:
Photodynamic therapy (PDT) has emerged as a minimally invasive and precision-guided cancer treatment method. However, single-modality PDT is limited by incomplete tumor ablation, and paradoxical immune evasion triggered by inflammatory cascades. Herein, we present BTDA-IMC, a nanoplatform that integrates an aggregation-induced emission (AIE) photosensitizer with a cyclooxygenase-2 (COX-2) inhibitor to synergistically enhance PDT efficacy.
View Article and Find Full Text PDFFolate-guided AIE nanoparticles integrate macrophage-targeted fluorescence imaging and photodynamic immunomodulation in rheumatoid arthritis.
Colloids Surf B Biointerfaces
August 2025
State Key Laboratory of Advanced Technology for Materials Synthesis and Processing, Wuhan University of Technology, Biomedical Materials and Engineering Research Center of Hubei Province, Wuhan 430070, PR China. Electronic address:
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation and macrophage-driven immune dysregulation. Here, we developed a multifunctional nanoplatform (FA@4BC NPs) by encapsulating an AIE-active curcumin-derived photosensitizer (4BC) within folate-functionalized PEGylated liposomes. The system enables precise targeting of activated macrophages through folate receptor-β (FR-β) recognition, and upon laser irradiation, efficiently generates singlet oxygen (O), promoting M1-to-M2 macrophage polarization and initiating anti-inflammatory signaling pathways.
View Article and Find Full Text PDFAIE-Augmented NIR-II-Emissive Supramolecular Metallacycle Nanoplatform for Tumor Microenvironment-Responsive Chemo-Photothermal-Immunotherapy.
Adv Healthc Mater
August 2025
Key Laboratory of Organosilicon Chemistry and Materials Technology of the Ministry of Education, Zhejiang Key Laboratory of Organosilicon Material Technology, College of Materials, Chemistry and Chemical Engineering, Hangzhou Normal University, Zhejiang, Hangzhou, 311121, P. R. China.
The integration of multimodal therapies into a single nanoplatform promises significant advances in precision oncology, yet structural instability, premature drug leakage, and insufficient immune activation remain key challenges. Herein, a supramolecular metallacycle-based nanoplatform (M2S-AD NPs) is engineered through coordination-driven self-assembly and β-cyclodextrin-mediated host-guest encapsulation. The metallacycle exhibits aggregation-induced emission (AIE) characteristics to amplify NIR-II fluorescence (1084 nm) for real-time tumor imaging and achieves a record-high photothermal conversion efficiency (42.
View Article and Find Full Text PDFAn AIE-active type I/II photosensitizer with mitochondria-to-nuclei cascade targeting for highly efficient photodynamic cancer therapy.
Mater Today Bio
October 2025
NMPA Key Laboratory for Research and Evaluation of Drug Metabolism & Guangdong Provincial Key Laboratory of New Drug Screening & Guangdong-Hongkong-Macao Joint Laboratory for New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, 510515, China.
photodynamic therapy (PDT) has emerged as a prominent strategy for the treatment of breast cancer, which is prevalent among women globally. Organelles targeted photosensitizers have brought great promise for enhancing the PDT efficiency. Photosensitizers possessing mitochondria and nuclei dual-targeting, especially those multipled with type I/II reactive oxygen species (ROS) generation and aggregation-induced emission (AIE) characteristics are urgently needed to improve the PDT efficiency.
View Article and Find Full Text PDF